{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:45:14Z","timestamp":1786653914658,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["PNC0000003"],"award-info":[{"award-number":["PNC0000003"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["101167421"],"award-info":[{"award-number":["101167421"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009433","name":"Istituto Auxologico Italiano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.numecd.2026.104754","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:38:20Z","timestamp":1775633900000},"page":"104754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma PCSK9 levels in children and adolescents: evidence from an Italian outpatient paediatric clinic cohort at cardio-metabolic risk"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-7061","authenticated-orcid":false,"given":"M.","family":"Ruscica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tassistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Rizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rebora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Giussani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.numecd.2026.104754_bib1","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMra1106700","article-title":"Proprotein convertases in health and disease","volume":"365","author":"Artenstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.numecd.2026.104754_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"issue":"42","key":"10.1016\/j.numecd.2026.104754_bib3","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route","volume":"284","author":"Poirier","year":"2009","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.numecd.2026.104754_bib4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/ATVBAHA.116.307995","article-title":"Carriers of the PCSK9 R46L variant are characterized by an antiatherogenic lipoprotein profile assessed by nuclear magnetic resonance spectroscopy-brief report","volume":"37","author":"Verbeek","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.numecd.2026.104754_bib6","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jacc.2019.03.517","article-title":"Low LDL cholesterol by PCSK9 variation reduces cardiovascular mortality","volume":"73","author":"Benn","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.numecd.2026.104754_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.numecd.2026.104754_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2514428","article-title":"Evolocumab in patients without a previous myocardial infarction or stroke","volume":"394","author":"Bohula","year":"2026","journal-title":"N Engl J Med."},{"issue":"22","key":"10.1016\/j.numecd.2026.104754_bib9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.numecd.2026.104754_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/jamacardio.2016.5395","article-title":"Association between circulating Baseline Proprotein Convertase Subtilisin Kexin type 9 levels and efficacy of Evolocumab","volume":"2","author":"Desai","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.numecd.2026.104754_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019525","article-title":"Circulating mature PCSK9 level predicts diminished response to Statin therapy","volume":"10","author":"Kuyama","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.numecd.2026.104754_bib12","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/jc.2009-0141","article-title":"Genetic and metabolic determinants of plasma PCSK9 levels","volume":"94","author":"Lakoski","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2026.104754_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2020.07.014","article-title":"Sex-specific predictors of PCSK9 levels in a European population: the IMPROVE study","volume":"309","author":"Ferri","year":"2020","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.numecd.2026.104754_bib14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1373\/clinchem.2009.126987","article-title":"Plasma PCSK9 is associated with age, sex, and multiple metabolic markers in a population-based sample of children and adolescents","volume":"55","author":"Baass","year":"2009","journal-title":"Clin Chem"},{"issue":"42","key":"10.1016\/j.numecd.2026.104754_bib15","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1093\/eurheartj\/ehad547","article-title":"Significance of lipids, lipoproteins, and apolipoproteins during the first 14-16 months of life","volume":"44","author":"Taageby Nielsen","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2026.104754_bib16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057957","article-title":"Cardiovascular risk assessment and management for pediatricians","volume":"150","author":"Schipper","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.numecd.2026.104754_bib17","author":"Statistics"},{"issue":"4","key":"10.1016\/j.numecd.2026.104754_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.2047-6310.2012.00064.x","article-title":"Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity","volume":"7","author":"Cole","year":"2012","journal-title":"Pediatr Obes"},{"issue":"239","key":"10.1016\/j.numecd.2026.104754_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"issue":"235","key":"10.1016\/j.numecd.2026.104754_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.numecd.2026.104754_bib21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.numecd.2026.104754_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.numecd.2026.104754_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"10.1016\/j.numecd.2026.104754_bib24","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.numecd.2026.104754_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00592-015-0782-4","article-title":"Reference ranges of HOMA-IR in normal-weight and obese young Caucasians","volume":"53","author":"Shashaj","year":"2016","journal-title":"Acta Diabetol"},{"issue":"7","key":"10.1016\/j.numecd.2026.104754_bib26","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/s41390-020-01185-9","article-title":"Uric acid reference values: report on 1750 healthy Brazilian children and adolescents","volume":"89","author":"Moulin-Mares","year":"2021","journal-title":"Pediatr Res"},{"issue":"42","key":"10.1016\/j.numecd.2026.104754_bib27","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12933-023-01948-8","article-title":"Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study","volume":"22","author":"Ruscica","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.numecd.2026.104754_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","article-title":"Obesity in children and adolescents: epidemiology, causes, assessment, and management","volume":"10","author":"Jebeile","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.numecd.2026.104754_bib30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/eurheartj\/ehv568","article-title":"Plasma proprotein convertase subtilisin\/kexin type 9 levels and the risk of first cardiovascular events","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2026.104754_bib31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/eurheartj\/ehv637","article-title":"Prognostic value of PCSK9 levels in patients with acute coronary syndromes","volume":"37","author":"Gencer","year":"2016","journal-title":"Eur Heart J"},{"issue":"10215","key":"10.1016\/j.numecd.2026.104754_bib32","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium","volume":"394","author":"Brunner","year":"2019","journal-title":"Lancet"},{"issue":"47","key":"10.1016\/j.numecd.2026.104754_bib33","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"issue":"47","key":"10.1016\/j.numecd.2026.104754_bib34","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.numecd.2026.104754_bib35","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/S0022-2275(20)33313-7","article-title":"Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages","volume":"39","author":"Fujioka","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2026.104754_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpeds.2021.01.019","article-title":"Elevated serum concentrations of remnant cholesterol associate with increased carotid intima-media thickness in children and adolescents","volume":"232","author":"Di Costanzo","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.numecd.2026.104754_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2018.01.025","article-title":"Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: facts and gaps","volume":"130","author":"Baragetti","year":"2018","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.numecd.2026.104754_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tem.2018.03.013","article-title":"Beyond LDL: what role for PCSK9 in triglyceride-rich lipoprotein metabolism?","volume":"29","author":"Dijk","year":"2018","journal-title":"Trends Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010331","article-title":"Metabolic determinants of PCSK9 regulation in women with polycystic ovary syndrome: the role of insulin resistance, obesity, and tobacco smoke exposure","volume":"27","author":"Niepsuj","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jacl.2025.09.027","article-title":"PCSK9-dyslipidemia interplay in children and adolescents with type 1 diabetes: a potential modulator of vasculopathy","volume":"20","author":"Salah","year":"2026","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.numecd.2026.104754_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/biof.1619","article-title":"Beyond cholesterol metabolism: the pleiotropic effects of proprotein convertase subtilisin\/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition","volume":"46","author":"Cesaro","year":"2020","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12933-020-01158-6","article-title":"Depression and cardiovascular risk-association among Beck depression Inventory, PCSK9 levels and insulin resistance","volume":"19","author":"Macchi","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.numecd.2026.104754_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028985","article-title":"Long-Term high level of insulin resistance is associated with an increased prevalence of coronary artery calcification: the CARDIA Study","volume":"12","author":"Ke","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.numecd.2026.104754_bib45","doi-asserted-by":"crossref","first-page":"oeaf127","DOI":"10.1093\/ehjopen\/oeaf127","article-title":"Children with heterozygous familial hypercholesterolaemia: routine lipoprotein(a) testing, earlier PCSK9 access, and pragmatic cascade screening","volume":"5","author":"Keogh","year":"2025","journal-title":"Eur Heart J Open"},{"issue":"5","key":"10.1016\/j.numecd.2026.104754_bib46","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc13-1697","article-title":"Predictors of metabolically healthy obesity in children","volume":"37","author":"Prince","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2026.104754_bib47","article-title":"Establishing serum proprotein convertase Subtilisin\/Kexin type 9 (PCSK9) reference intervals","volume":"582","author":"Giglio","year":"2025","journal-title":"Clin Chim Acta"},{"issue":"9","key":"10.1016\/j.numecd.2026.104754_bib48","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/2047487319831500","article-title":"Changes in circulating pro-protein convertase subtilisin\/kexin type 9 levels - experimental and clinical approaches with lipid-lowering agents","volume":"26","author":"Macchi","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.numecd.2026.104754_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071411","article-title":"Prognostic value of PCSK9 levels in premenopausal women at risk of breast cancer-evidence from a 17-Year Follow-Up Study","volume":"16","author":"Ruscica","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.numecd.2026.104754_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003348","article-title":"PCSK9 genetic variants, carotid atherosclerosis and vascular remodelling","volume":"12","author":"Coggi","year":"2025","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.numecd.2026.104754_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12902-023-01470-8","article-title":"Lipid profile in girls with precocious puberty: a systematic review and meta-analysis","volume":"23","author":"Jiang","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.numecd.2026.104754_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105222","article-title":"Unlike estrogens that increase PCSK9 levels post-menopause HSP27 vaccination lowers cholesterol levels and atherogenesis due to divergent effects on PCSK9 and LDLR","volume":"161","author":"Maarouf","year":"2020","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.numecd.2026.104754_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1194\/jlr.P023994","article-title":"Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia","volume":"53","author":"Huijgen","year":"2012","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.numecd.2026.104754_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12263-014-0388-4","article-title":"The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels","volume":"9","author":"Stojkovic","year":"2014","journal-title":"Gene Nutr"},{"issue":"12","key":"10.1016\/j.numecd.2026.104754_bib55","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1194\/jlr.P119000226","article-title":"A genome-wide search for gene-by-obesity interaction loci of dyslipidemia in Koreans shows diverse genetic risk alleles","volume":"60","author":"Kang","year":"2019","journal-title":"J Lipid Res"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:55:05Z","timestamp":1786650905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0939475326002164"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104754","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma PCSK9 levels in children and adolescents: evidence from an Italian outpatient paediatric clinic cohort at cardio-metabolic risk","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104754"}}